Cargando…
Biovalorized Okara Consumption Improves Gut Metabolites by Modulating Gut Microbiome: A Randomized Controlled Crossover Trial
OBJECTIVES: Okara is a major food by-product of soymilk or tofu production, particularly rich in dietary fiber. Biovalorization with Rhizopus oligosporus can improve its nutritional quality with greater soluble fiber, bioavailable isoflavones, and antioxidants. These nutrients are fermented by the g...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9193693/ http://dx.doi.org/10.1093/cdn/nzac069.022 |
_version_ | 1784726527417516032 |
---|---|
author | Lee, Delia Pei Shan Gan, Alicia Xinli Xia, Xuejuan Toh, Kate Qi Xuan Chan, Gregory Jung, Sangyong Kim, Jung Eun |
author_facet | Lee, Delia Pei Shan Gan, Alicia Xinli Xia, Xuejuan Toh, Kate Qi Xuan Chan, Gregory Jung, Sangyong Kim, Jung Eun |
author_sort | Lee, Delia Pei Shan |
collection | PubMed |
description | OBJECTIVES: Okara is a major food by-product of soymilk or tofu production, particularly rich in dietary fiber. Biovalorization with Rhizopus oligosporus can improve its nutritional quality with greater soluble fiber, bioavailable isoflavones, and antioxidants. These nutrients are fermented by the gut microbiota to generate gut metabolites involved in gut health maintenance. This study evaluates the impact of okara and biovalorized okara- containing biscuits consumption on gut health in middle-aged and older Singaporeans. METHODS: Healthy participants (n = 15) of the crossover trial were randomly allocated to 3-week interventions of 100 g of control (C), 20% flour substituted autoclaved okara- (AOK), and 20% four substituted R. oligosporus biovalorized okara- (RO) containing biscuits, with 3-week washout periods. Pre- and post- intervention serum short-chain fatty acids (SCFA), fecal SCFA, fecal bile acids, serum zonulin, gastrointestinal symptoms, and dietary intakes were assessed. Pre- and post- intervention fecal 16S ribosomal RNA V3-V4 sequencing was also investigated for gut microbiome analysis. Results are presented as change value mean (95% confidence interval). RESULTS: Amongst fecal SCFA, only valeric acid (µmol/g) observed a significant difference, higher with RO compared to AOK (0.16 (0.01, 0.30) vs −0.20 (−0.34, −0.05), P = 0.005). RO and AOK had significantly higher total serum SCFA (P = 0.002 & 0.018 respectively) and serum acetic acid (P = 0.007 & 0.030 respectively) compared to C. RO had significant improvements with higher serum propionic acid (µmol/L) (RO: 3.04 (0.80, 5.27) vs C: −2.65 (−4.97, −0.33), P = 0.004) and lower fecal lithocholic acid (mg/g) (a secondary bile acid) (RO: −0.11 (−0.20, −0.02) vs C: 0.10 (0.01, 0.19), P = 0.009) contrasted to C. Although serum zonulin showed no significant difference, AOK induced a reduction in Clostridiales while RO increased Bifidobacterium. Okara consumption increased dietary fiber intake, with greater soluble fiber intake from RO compared to AOK and C (P = 0.018 & 0.019 respectively), aligning with the greater flatulence felt by participants on RO. CONCLUSIONS: Okara consumption improved serum SCFA rather than fecal SCFA, regardless of fermentation. Biovalorized okara consumption further improved SCFA and bile acid profiles by modulating gut microbiome. FUNDING SOURCES: Singapore Ministry of Education. |
format | Online Article Text |
id | pubmed-9193693 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-91936932022-06-14 Biovalorized Okara Consumption Improves Gut Metabolites by Modulating Gut Microbiome: A Randomized Controlled Crossover Trial Lee, Delia Pei Shan Gan, Alicia Xinli Xia, Xuejuan Toh, Kate Qi Xuan Chan, Gregory Jung, Sangyong Kim, Jung Eun Curr Dev Nutr Nutritional Microbiology/Microbiome OBJECTIVES: Okara is a major food by-product of soymilk or tofu production, particularly rich in dietary fiber. Biovalorization with Rhizopus oligosporus can improve its nutritional quality with greater soluble fiber, bioavailable isoflavones, and antioxidants. These nutrients are fermented by the gut microbiota to generate gut metabolites involved in gut health maintenance. This study evaluates the impact of okara and biovalorized okara- containing biscuits consumption on gut health in middle-aged and older Singaporeans. METHODS: Healthy participants (n = 15) of the crossover trial were randomly allocated to 3-week interventions of 100 g of control (C), 20% flour substituted autoclaved okara- (AOK), and 20% four substituted R. oligosporus biovalorized okara- (RO) containing biscuits, with 3-week washout periods. Pre- and post- intervention serum short-chain fatty acids (SCFA), fecal SCFA, fecal bile acids, serum zonulin, gastrointestinal symptoms, and dietary intakes were assessed. Pre- and post- intervention fecal 16S ribosomal RNA V3-V4 sequencing was also investigated for gut microbiome analysis. Results are presented as change value mean (95% confidence interval). RESULTS: Amongst fecal SCFA, only valeric acid (µmol/g) observed a significant difference, higher with RO compared to AOK (0.16 (0.01, 0.30) vs −0.20 (−0.34, −0.05), P = 0.005). RO and AOK had significantly higher total serum SCFA (P = 0.002 & 0.018 respectively) and serum acetic acid (P = 0.007 & 0.030 respectively) compared to C. RO had significant improvements with higher serum propionic acid (µmol/L) (RO: 3.04 (0.80, 5.27) vs C: −2.65 (−4.97, −0.33), P = 0.004) and lower fecal lithocholic acid (mg/g) (a secondary bile acid) (RO: −0.11 (−0.20, −0.02) vs C: 0.10 (0.01, 0.19), P = 0.009) contrasted to C. Although serum zonulin showed no significant difference, AOK induced a reduction in Clostridiales while RO increased Bifidobacterium. Okara consumption increased dietary fiber intake, with greater soluble fiber intake from RO compared to AOK and C (P = 0.018 & 0.019 respectively), aligning with the greater flatulence felt by participants on RO. CONCLUSIONS: Okara consumption improved serum SCFA rather than fecal SCFA, regardless of fermentation. Biovalorized okara consumption further improved SCFA and bile acid profiles by modulating gut microbiome. FUNDING SOURCES: Singapore Ministry of Education. Oxford University Press 2022-06-14 /pmc/articles/PMC9193693/ http://dx.doi.org/10.1093/cdn/nzac069.022 Text en © The Author 2022. Published by Oxford University Press on behalf of The International Society for Human and Animal Mycology. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
spellingShingle | Nutritional Microbiology/Microbiome Lee, Delia Pei Shan Gan, Alicia Xinli Xia, Xuejuan Toh, Kate Qi Xuan Chan, Gregory Jung, Sangyong Kim, Jung Eun Biovalorized Okara Consumption Improves Gut Metabolites by Modulating Gut Microbiome: A Randomized Controlled Crossover Trial |
title | Biovalorized Okara Consumption Improves Gut Metabolites by Modulating Gut Microbiome: A Randomized Controlled Crossover Trial |
title_full | Biovalorized Okara Consumption Improves Gut Metabolites by Modulating Gut Microbiome: A Randomized Controlled Crossover Trial |
title_fullStr | Biovalorized Okara Consumption Improves Gut Metabolites by Modulating Gut Microbiome: A Randomized Controlled Crossover Trial |
title_full_unstemmed | Biovalorized Okara Consumption Improves Gut Metabolites by Modulating Gut Microbiome: A Randomized Controlled Crossover Trial |
title_short | Biovalorized Okara Consumption Improves Gut Metabolites by Modulating Gut Microbiome: A Randomized Controlled Crossover Trial |
title_sort | biovalorized okara consumption improves gut metabolites by modulating gut microbiome: a randomized controlled crossover trial |
topic | Nutritional Microbiology/Microbiome |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9193693/ http://dx.doi.org/10.1093/cdn/nzac069.022 |
work_keys_str_mv | AT leedeliapeishan biovalorizedokaraconsumptionimprovesgutmetabolitesbymodulatinggutmicrobiomearandomizedcontrolledcrossovertrial AT ganaliciaxinli biovalorizedokaraconsumptionimprovesgutmetabolitesbymodulatinggutmicrobiomearandomizedcontrolledcrossovertrial AT xiaxuejuan biovalorizedokaraconsumptionimprovesgutmetabolitesbymodulatinggutmicrobiomearandomizedcontrolledcrossovertrial AT tohkateqixuan biovalorizedokaraconsumptionimprovesgutmetabolitesbymodulatinggutmicrobiomearandomizedcontrolledcrossovertrial AT changregory biovalorizedokaraconsumptionimprovesgutmetabolitesbymodulatinggutmicrobiomearandomizedcontrolledcrossovertrial AT jungsangyong biovalorizedokaraconsumptionimprovesgutmetabolitesbymodulatinggutmicrobiomearandomizedcontrolledcrossovertrial AT kimjungeun biovalorizedokaraconsumptionimprovesgutmetabolitesbymodulatinggutmicrobiomearandomizedcontrolledcrossovertrial |